Dogecoin Cash Stock Price, News & Analysis

Dogecoin Cash Inc. (OTCQB: CBDS) has received approval to change its stock ticker symbol to DOGP, effective June 10, 2025. The company, which operates PrestoDoctor, a telehealth platform for cannabis consultations, aims to strengthen its position in the meme economy and blockchain space. The company's assets include a patented cannabis strain (Ecuadorian Sativa), a patented cannabis lozenge for hypertension treatment, and 1 billion DOG tokens acquired from Tipestry Inc. Recent milestones include the launch of Meme Coins Inc., a subsidiary focused on meme asset development, and the issuance of preferred stock dividends to shareholders. The symbol change represents the company's strategy to bridge traditional capital markets with decentralized finance while maintaining SEC compliance.

MEME Coins Inc., a subsidiary of Dogecoin Cash Inc. (OTC: CBDS), has completed the acquisition of 1 billion DogeCoin Cash (DOG) tokens from Tipestry Inc. The transaction was executed through the issuance of 125,000 preferred MEME Coins shares, reduced from the initially proposed 500,000 shares. The acquisition increases CBDS' total DOG holdings to 1.6 billion tokens, with the transferred tokens verifiable on the Binance Smart Chain. Dogecoin Cash Inc. operates PrestoDoctor, a medical cannabis telemedicine platform, and holds patents for a cannabis strain and hypertension treatment lozenge. The company is expanding its focus to blockchain innovation and digital asset initiatives through its MEME Coins subsidiary.

Dogecoin Cash (OTC: CBDS) has confirmed the finalization of its previously announced stock dividend distribution, now published on FINRA's Daily List. The dividend will be paid on May 9, 2025, with a record date of November 25, 2024. For every 1,000 shares of common stock, shareholders will receive one share of unrestricted Series A Preferred stock.

The preferred shares come with unique features: they entitle holders to receive one common share annually (if declared by the Board) for holders of record as of November 25 each year. While not convertible, the company can redeem these preferred shares before October 25, 2034, at a rate of 10 common shares per preferred share. Fractional shares will be rounded up, and no ex-dividend date has been set.

Dogecoin Cash (OTC: CBDS) has officially completed its corporate name change, as confirmed through FINRA notification. The transformation became market effective on April 25, 2025, following the initial authorization via a Certificate of Amendment filed with the Nevada Secretary of State in November 2024.

Key updates include:

• Name change is now reflected across U.S. stock market systems
• Trading symbol CBDS remains unchanged
• SEC Form 8-K filing completed on April 28, 2025
• Original amendment filed on November 13, 2024

The company will maintain transparency through its public filings and official communication channels as developments continue.

Dogecoin Cash (OTCIQ: CBDS) subsidiary PrestoDoctor announces its largest-ever discount promotion for April 2025, offering 42.0% off medical cannabis card evaluations and renewals. The promotion, celebrating the cultural cannabis date 4/20, is available to both new and returning patients in participating states through PrestoDoctor's HIPAA-compliant telemedicine platform.

Through the company's digital platform, patients can schedule same-day appointments for video consultations with licensed physicians, receiving immediate digital recommendations and official documentation by mail. The service emphasizes accessibility and convenience in obtaining medical cannabis evaluations.

Dogecoin Cash (OTC: CBDS) has announced that its subsidiary, MEME Coins Inc., has entered into a definitive agreement with Tipestry, Inc. to acquire 1 billion Dogecoin Cash (DOG) tokens. The deal involves MEME Coins Inc. issuing 500,000 preferred shares valued at $20.00 each to Tipestry in exchange for the tokens.

This marks MEME Coins' third DOG acquisition, bringing their total holdings to 2.02 billion DOG tokens. The agreement, executed on March 12, 2025, involves no dilution to existing common shareholders of Dogecoin Cash. The transaction will be completed upon mutual fulfillment of obligations and is governed by Colorado state laws.

CBDS operates PrestoDoctor, a medical cannabis telemedicine platform, and holds patents for an Ecuadorian Sativa cannabis strain and a hypertension treatment lozenge. The company focuses on cannabis product development, telemedicine, and blockchain innovation.

Dogecoin Cash ($CBDS) has announced its expansion into the meme coin market through the formation of a new subsidiary, MEME COINS Inc. The company aims to capitalize on the growing meme coin trend while protecting shareholder equity through a strategic approach that avoids dilution.

The subsidiary will focus on three main strategies:

• Developing proprietary meme coins with real-world applications
• Partnering with influencers for viral marketing
• Creating a community-first ecosystem for trading and governance

MEME COINS Inc. will raise funds through preferred shares rather than common stock to maintain current equity positions. The subsidiary plans to acquire established meme coins like Dogecoin and invest in new projects with strong community engagement. The company cites the recent success of high-profile meme coin launches and the market's billions in daily trading volume as key drivers for this strategic expansion.

Dogecoin Cash (OTCQB: CBDS) has announced a definitive agreement with Bots, Inc. (BTZI) to acquire 420 million DogeCoin Cash ($DOG) tokens in exchange for 4.2 million shares of CBDS common stock. The transaction is set to close on March 1, 2025, with CBDS establishing a Binance Wallet for the token transfer.

This acquisition follows CBDS's previous purchase of 600 million $DOG from DogeSPAC, Upon completion, CBDS's total $DOG holdings will reach 1.02 billion tokens. The agreement with Bots, Inc. represents a transfer of 50% of their $DOG holdings, which currently total 840 million tokens.

The company also provided an update regarding its preferred dividend, indicating that FINRA is not expected to set an ex-dividend date, meaning only shareholders who held common shares on November 25, 2024, will likely receive the preferred shares.